University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,742 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
982 of 1,090 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,423 total, page 19 of 29
Healthy In-Store Marketing Study
NCT02499211
Risk of Falling After CFNB Versus ACB
NCT02314832
Eating Phenotypes for Childhood Obesity in the Context of Familial Obesity Risk
NCT02928874
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
NCT02316678
Exploratory Study of Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics
NCT02249793
Smartphone Based Continuing Care for Alcohol
NCT02681406
Sustained Aeration of Infant Lungs Trial
NCT02139800
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
NCT02225106
HIV/STI Prevention Among Black Adolescents With Mental Illnesses (Project GOLD)
NCT03348813
Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood
NCT02225041
Sodium-restricted Diets and Symptoms in End Stage Renal Disease: An RCT
NCT02778516
Stress and Inflammation in Late-Life Depression
NCT02389465
Evive Health Randomized Controlled Trials
NCT01653197
Using IT to Improve Access, Communication and Asthma in African American and Hispanic/Latino Adults
NCT02086565
Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
NCT02187172
The Effect of a Scratch Off Prompt on Health Engagement
NCT01401621
MRI of Glymphatic Clearance During Anesthetic Sedation
NCT02768688
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
NCT02198092
Handoffs and Transitions in Critical Care
NCT02267174
Affordable Mobile Robots for the Elderly
NCT02807506
Choice Sets for Advance Directives
NCT02209038
Feeding Progression in Preterm Infants
NCT02027688
Precision Medicine for Preterm Birth
NCT02173210
Fecal Incontinence Subtypes in Women With Pelvic Floor Disorders
NCT02772874
A Cost-Effective Handheld Breast Scanner for Use in Low Resource Environments: A Validation Study
NCT02814292
Escitalopram Effects on CSF Amyloid Beta
NCT02161458
Incentives for Daily Tooth Brushing to Reduce Gingivitis
NCT02160418
Fish Oils and Adipose Inflammation Reduction
NCT02010359
CART-meso in Mesothelin Expressing Cancers
NCT02159716
Incentive Disbursement Pattern
NCT02154256
Clinic-based Intervention to Promote Cervical Cancer Prevention Behaviors
NCT02046265
Medicaid Incentives for the Prevention of Chronic Diseases: Diabetes Prevention
NCT03139019
Peroral Endoscopic Myotomy (POEM) for Esophageal Motility
NCT02314741
PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population
NCT02128997
Heartstrong Pilot Program
NCT02139202
Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17)
NCT01994369
Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects
NCT02154360
CART-19 for Multiple Myeloma
NCT02135406
Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
NCT02154711
The Impact of Doulas in Early Pregnancy Management
NCT02165540
Contraceptive Hormones and Women With Cystic Fibrosis
NCT02144246
Arm Motor Control on Bi and Uni ADLs
NCT02778529
Zaleplon in HIV Patients With Depression
NCT03489304
Preventing Risky Drinking in Veterans Treated With Prescription Opioids
NCT02709317
Comparison of Outreach Approaches to Increase Enrollment in a Healthy Cholesterol Study
NCT02086539
Physical Exercise and Bladder Training Program for Urinary Incontinence
NCT03869918
Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy
NCT02374333
Circadian Brown Adipose Tissue Metabolism
NCT02285270
Clinical Utility Study of a Low-Cost Hand-Held Breast Scanner
NCT02597452
Safety of Simvastatin in LAM and TSC
NCT02061397
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Pennsylvania: open-pipeline peers nationwide
Peers matched on 1,423 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
University of Pennsylvania sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,423 trials (± recruiting share)
- Johns Hopkins University · 1,448 trials · 17% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
- Yale University · 1,492 trials · 17% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Seattle Institute for Biomedical and Clinical Research · 14% recruiting · 43 trials
- University of Illinois at Urbana-Champaign · 14% recruiting · 129 trials
- Johns Hopkins Bloomberg School of Public Health · 14% recruiting · 187 trials
- Milton S. Hershey Medical Center · 14% recruiting · 396 trials
Related
What to do with this University of Pennsylvania page
1,423 registered trials is a research-attention snapshot, not an endorsement of University of Pennsylvania or any single study.
- 199 of University of Pennsylvania's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Pennsylvania studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pennsylvania pipeline card: 1,423 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.